| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 1994;107:472-0481
© 1994 Mosby, Inc.
Cardiac and Pulmonary Transplantation |
St. Louis, Mo.
Address for reprints: D. Glenn Pennington, MD, Department of Surgery, 3635 Vista Ave. at Grand Blvd., P.O. Box 15250, St. Louis, MO 63110-0250.
Abstract
Although bridging to cardiac transplantation has become a therapeutic option for transplant candidates whose condition deteriorates while they are awaiting a donor heart, short-term efficacy has not been proved and long-term survival has not been reported. We retrospectively reviewed data on 44 patients who had circulatory assist devices placed as a bridge to transplantation between May 1985 and April 1993. The 35 male and nine female patients ranged in age from 12 to 65 years (mean 43.8 years). Thirty-one patients were supported with 32 Thoratec (18 left ventricular, 14 biventricular), 11 Novacor, and two Jarvik J-7-70 devices. The duration of device support was from 4 hours to 440 days (mean 45.5 days). Fifteen patients did not receive a donor organ because of infection (ten patients), renal failure (five patients), bleeding (nine patients), cerebrovascular accident (three patients), ventricular fibrillation (one patient), and right heart failure (one patient), and all died. Two patients were weaned from support and survived without transplantation. Twenty-seven patients underwent transplantation, and 26 survived (96%). Overall survival was 64% (28/44). Duration of survival ranged from 2 to 96 months (mean 35 months). Among the 28 hospital survivors, there were four late deaths (all transplant recipients) at 3, 6, 14, and 68 months. Posttransplantation actuarial survivals at 1, 5, and 8 years are 88%, 83%, and 66%. Twenty-three of the 24 patients presently alive are in New York Heart Association functional class I. These data demonstrate the short- and long-term efficacy of bridging to transplantation with circulatory support devices. The excellent survival and full functional recovery of patients undergoing transplantation ensure that donor organs are not being "wasted" on the sickest patients. (J THORAC CARDIOVASC SURG 1994;107:472-81)
This article has been cited by other articles:
|
|
 |
|
  J. W. Long, A. H. Healy, B. Y. Rasmusson, C. G. Cowley, K. E. Nelson, A. G. Kfoury, S. E. Clayson, B. B. Reid, S. A. Moore, D. U. Blank, et al. Improving outcomes with long-term "destination" therapy using left ventricular assist devices. J. Thorac. Cardiovasc. Surg., June 1, 2008; 135(6): 1353 - 1361. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Dittrich and E. B. Ringelstein Occurrence and Clinical Impact of Microembolic Signals During or After Cardiosurgical Procedures Stroke, February 1, 2008; 39(2): 503 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Williams and J. Conte Ventricular assist device placement following surgical ventricular restoration Interactive CardioVascular and Thoracic Surgery, April 1, 2006; 5(2): 90 - 91. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. H. Thoennissen, M. Schneider, A. Allroggen, M. Ritter, R. Dittrich, C. Schmid, H. H. Scheld, E. B. Ringelstein, and D. G. Nabavi High level of cerebral microembolization in patients supported with the DeBakey left ventricular assist device J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 1159 - 1166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Park, A. Tector, W. Piccioni, E. Raines, A. Gelijns, A. Moskowitz, E. Rose, W. Holman, S. Furukawa, O. H. Frazier, et al. Left ventricular assist devices as destination therapy: A new look at survival J. Thorac. Cardiovasc. Surg., January 1, 2005; 129(1): 9 - 17. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Morgan, R. John, V. Rao, A. D. Weinberg, B. J. Lee, P. A. Mazzeo, M. R. Flannery, J. M. Chen, M. C. Oz, and Y. Naka Bridging to transplant with the HeartMate left ventricular assist device: The Columbia Presbyterian 12-year experience J. Thorac. Cardiovasc. Surg., May 1, 2004; 127(5): 1309 - 1316. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Morgan, R. John, B. J. Lee, M. C. Oz, and Y. Naka Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality Ann. Thorac. Surg., March 1, 2004; 77(3): 859 - 863. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Fries, P. Innerhofer, W. Streif, W. Schobersberger, J. Margreiter, H. Antretter, and C. Hormann Coagulation monitoring and management of anticoagulation during cardiac assist device support Ann. Thorac. Surg., November 1, 2003; 76(5): 1593 - 1597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Morgan, Y. Park, A. R. Kherani, D. W. Vigilance, F. H. Cheema, M. C. Oz, and Y. Naka Does bridging to transplantation with a left ventricular assist device adversely affect posttransplantation survival? A comparative analysis of mechanical versus inotropic support J. Thorac. Cardiovasc. Surg., October 1, 2003; 126(4): 1188 - 1190. [Full Text] [PDF]
|
|
|
|
|
|
K. D. Aaronson, H. Patel, and F. D. Pagani Patient selection for left ventricular assist device therapy Ann. Thorac. Surg., June 1, 2003; 75(90060): S29 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. R. McBride, K. S. Naunheim, A. C. Fiore, R. G. Johnson, D. A. Moroney, J. A. Brannan, and M. T. Swartz Risk analysis in patients bridged to transplantation Ann. Thorac. Surg., June 1, 2001; 71(6): 1839 - 1844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.W. Quinn, T.J.J. Jones, and T.R. Graham Mechanical Circulatory Support Sources of Emboli and Neurological Outcome Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 2000; 4(2): 115 - 120. [Abstract] [PDF]
|
|
|
|
 |
|
 J. R Pepper Surgery for heart failure: options and outcomes Perfusion, July 1, 2000; 15(4): 287 - 293. [PDF]
|
|
|
|
|
|
R. Korfer, A. El-Banayosy, L. Arusoglu, K. Minami, M. M. Korner, L. Kizner, O. Fey, U. Schutt, M. Morshuis, and H. Posival SINGLE-CENTER EXPERIENCE WITH THE THORATEC VENTRICULAR ASSIST DEVICE J. Thorac. Cardiovasc. Surg., March 1, 2000; 119(3): 596 - 600. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. B. Spanier, J. M. Chen, M. C. Oz, D. M. Stern, E. A. Rose, and A. M. Schmidt TIME-DEPENDENT CELLULAR POPULATION OF TEXTURED-SURFACE LEFT VENTRICULAR ASSIST DEVICES CONTRIBUTES TO THE DEVELOPMENT OF A BIPHASIC SYSTEMIC PROCOAGULANT RESPONSE J. Thorac. Cardiovasc. Surg., September 1, 1999; 118(3): 404 - 413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Korfer, A. El-Banayosy, L. Arusoglu, K. Minami, T. Breymann, D. Seifert, and L. Kizner Temporary pulsatile ventricular assist devices and biventricular assist devices Ann. Thorac. Surg., August 1, 1999; 68(2): 678 - 683. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Pennington, T. E. Oaks, and D. P. Lohmann Permanent ventricular assist device support versus cardiac transplantation Ann. Thorac. Surg., August 1, 1999; 68(2): 729 - 733. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Fastenau, D. R. Wagenknecht, and J. A. McIntyre Increased incidence of antiphospholipid antibodies in left ventricular assist system recipients Ann. Thorac. Surg., July 1, 1999; 68(1): 137 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. R. McBride, K. S. Naunheim, A. C. Fiore, D. A. Moroney, and M. T. Swartz Clinical experience with 111 thoratec ventricular assist devices Ann. Thorac. Surg., May 1, 1999; 67(5): 1233 - 1238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Rose, A. J. Moskowitz, M. Packer, J. A. Sollano, D. L. Williams, A. R. Tierney, D. F. Heitjan, P. Meier, D. D. Ascheim, R. G. Levitan, et al. The REMATCH trial: rationale, design, and end points Ann. Thorac. Surg., March 1, 1999; 67(3): 723 - 730. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Goldstein, M. C. Oz, and E. A. Rose Implantable Left Ventricular Assist Devices N. Engl. J. Med., November 19, 1998; 339(21): 1522 - 1533. [Full Text] [PDF]
|
|
|
|
 |
|
 J P Bourke, A Loaiza, G Parry, C Hilton, S Furniss, J Dark, and J Forty Role of orthotopic heart transplantation in the management of patients with recurrent ventricular tachyarrhythmias following myocardial infarction Heart, November 1, 1998; 80(5): 473 - 478. [Abstract] [Full Text]
|
|
|
|
|
|
O. Reinhartz, D. J. Farrar, J. H. Hershon, G. J. Avery Jr, E. A. Haeusslein, and J. D. Hill Importance of preoperative liver function as a predictor of survival in patients supported with Thoratec ventricular assist devices as a bridge to transplantation J. Thorac. Cardiovasc. Surg., October 1, 1998; 116(4): 633 - 640. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Herrmann, M. Weyand, B. Greshake, C. von Eiff, R. A. Proctor, H. H. Scheld, and G. Peters Left Ventricular Assist Device Infection Is Associated With Increased Mortality but Is Not a Contraindication to Transplantation Circulation, February 18, 1997; 95(4): 814 - 817. [Abstract] [Full Text]
|
|
|
|
|
|
J. P. Slater, E. A. Rose, H. R. Levin, O. H. Frazier, J. K. Roberts, A. D. Weinberg, and M. C. Oz Low Thromboembolic Risk Without Anticoagulation Using Advanced-Design Left Ventricular Assist Devices Ann. Thorac. Surg., November 1, 1996; 62(5): 1321 - 1327. [Abstract] [Full Text]
|
|
|
|
|
|
W. E. Richenbacher and W. S. Pierce Mechanical Circulatory Support Ann. Thorac. Surg., November 1, 1996; 62(5): 1558 - 1559. [Full Text]
|
|
|
|
|
|
T. Spanier, M. Oz, H. Levin, A. Weinberg, K. Stamatis, D. Stern, E. Rose, and A. M. Schmidt ACTIVATION OF COAGULATION AND FIBRINOLYTIC PATHWAYS IN PATIENTS WITH LEFT VENTRICULAR ASSIST DEVICES J. Thorac. Cardiovasc. Surg., October 1, 1996; 112(4): 1090 - 1097. [Abstract] [Full Text]
|
|
|
|
|
|
D.G. Nabavi, D. Georgiadis, T. Mumme, C. Schmid, T.G. Mackay, H.H. Scheld, and E.B. Ringelstein Clinical Relevance of Intracranial Microembolic Signals in Patients With Left Ventricular Assist Devices : A Prospective Study Stroke, May 1, 1996; 27(5): 891 - 896. [Abstract] [Full Text]
|
|
|
|
|
|
A. El-Banayosy, H. Posival, K. Minami, L. Arusoglu, L. Kizner, T. Breymann, D. Seifert, M. Korner, H. Kortke, O. Fey, et al. Mechanical circulatory support: lessons from a single centre Perfusion, March 1, 1996; 11(2): 93 - 102. [Abstract] [PDF]
|
|
|
|
|
|
M. Miyama, W. C. Dihmis, P. H. Deleuze, Y. Uozaki, S. L. Bambang, F. Pasteau, N. Rostaqui, and D. Y. Loisance The Gastrointestinal Tract: An Underestimated Organ as Demonstrated in an Experimental LVAD Pig Model Ann. Thorac. Surg., March 1, 1996; 61(3): 817 - 822. [Abstract] [Full Text]
|
|
|
|
|
|
R. Korfer, A. El-Banayosy, H. Posival, K. Minami, L. Kizner, L. Arusoglu, and M. M. Korner Mechanical Circulatory Support With the Thoratec Assist Device in Patients With Postcardiotomy Cardiogenic Shock Ann. Thorac. Surg., January 1, 1996; 61(1): 314 - 316. [Abstract] [Full Text]
|
|
|
|
|
|
H. O. Vetter, H. G. Kaulbach, C. Schmitz, A. Forst, P. Uberfuhr, E. Kreuzer, M. Pfeiffer, P. Brenner, O. Dewald, B. Reichart, et al. Experience with the Novacor left ventricular assist system as a bridge to cardiac transplantation, including the new wearable system J. Thorac. Cardiovasc. Surg., January 1, 1995; 109(1): 74 - 80. [Abstract] [Full Text]
|
|
|
|
|
|
E. A. Rose, A. C. Gelijns, A. J. Moskowitz, D. F. Heitjan, L. W. Stevenson, W. Dembitsky, J. W. Long, D. D. Ascheim, A. R. Tierney, R. G. Levitan, et al. Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart Failure N. Engl. J. Med., November 15, 2001; 345(20): 1435 - 1443. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
